Herein, we report on a patient diagnosed with gastric cancer that had metastasized to multiple bones, along with lymphangitis carcinomatosa in the lungs, harboring Her-2 amplification and c-MET amplification with poor PS (PS = 3) that positively responded to a combinational therapy of trastuzumab and crizotinib. The gene discussed is MET; the disease is gastric cancer.